TB-500
Men's HealthMale-physiology practitioners evaluate TB-500 against the HPG axis, androgenic markers, and downstream effects on body composition, libido, and recovery. Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local.. For men running TB-500 alongside TRT, post-cycle restarts, or fertility-aware protocols, baseline labs (total/free testosterone, LH, FSH, estradiol, prolactin, SHBG) and a 6-8 week follow-up panel are the standard monitoring framework at the 2-5 mg 1-2x weekly subq (loading phase); maintenance lower dose.
Key Takeaways
Male-physiology lens: TB-500 is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations. Mechanism: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel. Male dose: 2-5 mg 1-2x weekly subq (loading phase); maintenance lower via subq/im; cycle 8-12 weeks. Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.
Male users' practical questions about TB-500 reduce to: hormonal coherence, TRT integration, and prostate / cardiovascular safety. Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local. The mechanism shapes the answer to each. The subsections below work through HPG-axis impact and TRT compatibility before examining the body composition and male-physiology response.
Compatibility with TRT and post-cycle protocols
For men currently on TRT or planning a post-cycle restart, TB-500 is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.
Interaction with the HPG axis
TB-500's relationship to the male HPG axis is one of the central practical questions. Direct receptor-level engagement of the HPG axis is not the principal mechanism, but downstream effects on testosterone, LH/FSH, and prolactin can still occur and warrant baseline and follow-up labs in male users. The practical takeaway is that any male user beginning a course of TB-500 should have a baseline hormone panel and a follow-up at 6–8 weeks to detect drift.
Sexual function and prostate considerations
Where TB-500 alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.
For strength & power in male users, TB-500 is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.
Fat Loss (Male) in men responds to TB-500 with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.
Where male users target muscle mass, TB-500 is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.
For recovery in male users, TB-500 is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 2-5 mg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 1-5 mg | 4–6 weeks initial cycle |
| Men's Health focus | SubQ | 2-5 mg | 1-2x weekly SubQ (loading phase); maintenance lower |
| Maintenance phase | SubQ | 1-5 mg | Ongoing with periodic pauses |
Dose timing for TB-500 is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
TB-500 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.
- TB-500 + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with TB-500's mechanism in male physiology protocols.
- TB-500 + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with TB-500's mechanism in male physiology protocols.
- TB-500 + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with TB-500's mechanism in male physiology protocols.
- TB-500 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with TB-500's mechanism in male physiology protocols.
Generally well tolerated. Limited human safety data. Avoid in active cancer.
Lens-specific safety considerations for male physiology use of TB-500: Generally well tolerated. Limited human safety data. Avoid in active cancer. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | Men's Health |
| Kisspeptin | Hypothalamic upstream regulator of GnRH | ~28 min IV | The upstream master regulator of GnRH neurons — driving the entire HPG axis from above |
| Gonadorelin (GnRH) | Hypothalamic decapeptide | ~2-4 min | The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy |
| PT-141 | Melanocortin receptor agonist | ~2-3 hr | An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women |
Best time of day to dose for male users?
Is TB-500 compatible with TRT?
Will TB-500 affect fertility or sperm quality?
Can I use TB-500 during a cut?
Is TB-500 safe during pregnancy or breastfeeding?
Should I cycle TB-500?
Start a TB-500 Protocol
Alukard provides physician-supervised men's health protocols with GMP-certified TB-500 and GMP-certified compounds with comprehensive hormone panels.
Get ProtocolQuick Facts
- Molecular weight
- 888-1717 Da (depending on form)
- Sequence length
- 17 aa
- Half-life
- ~2-3 days
- WADA
- Banned (S0)
- FDA
- Unapproved
- Research
- Preclinical + veterinary clinical (equine)
All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for TB-500 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Male Physiology Protocol for TB-500
Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.
HIPAA Compliant · GMP Certified · Physician Supervised